Contrary to several previous studies, we found that JNK acts as the uppermost signaling molecule in this EGCG/As-mediated EC apoptotic signaling pathway, and therefore use of a JNK inhibitor may protect from EC toxicity-related diseases such as atherosclerosis [40] and infarction [41]. Here, MAPK8 is linked to atherosclerosis.